GENMAB AS revenue breakdown overview

GENMAB AS revenue for the last year amounted to 62.11 B MXN, the most of which — 62.11 B MXN — came from its highest performing source at the moment, Antibody Therapeutics, the year earlier bringing 41.42 B MXN. The greatest contribution to the revenue figure was made by Denmark — last year it brought GENMAB AS 57.08 B MXN, and the year before that — 40.36 B MXN.